1. Home
  2. JVA vs IMNN Comparison

JVA vs IMNN Comparison

Compare JVA & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JVA
  • IMNN
  • Stock Information
  • Founded
  • JVA 1971
  • IMNN 1982
  • Country
  • JVA United States
  • IMNN United States
  • Employees
  • JVA N/A
  • IMNN N/A
  • Industry
  • JVA Packaged Foods
  • IMNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • JVA Consumer Staples
  • IMNN Health Care
  • Exchange
  • JVA Nasdaq
  • IMNN Nasdaq
  • Market Cap
  • JVA N/A
  • IMNN 12.2M
  • IPO Year
  • JVA 2005
  • IMNN 1985
  • Fundamental
  • Price
  • JVA $3.68
  • IMNN $0.83
  • Analyst Decision
  • JVA
  • IMNN Strong Buy
  • Analyst Count
  • JVA 0
  • IMNN 2
  • Target Price
  • JVA N/A
  • IMNN $20.50
  • AVG Volume (30 Days)
  • JVA 163.7K
  • IMNN 395.1K
  • Earning Date
  • JVA 02-07-2025
  • IMNN 11-07-2024
  • Dividend Yield
  • JVA N/A
  • IMNN N/A
  • EPS Growth
  • JVA N/A
  • IMNN N/A
  • EPS
  • JVA 0.20
  • IMNN N/A
  • Revenue
  • JVA $76,111,698.00
  • IMNN N/A
  • Revenue This Year
  • JVA N/A
  • IMNN N/A
  • Revenue Next Year
  • JVA N/A
  • IMNN N/A
  • P/E Ratio
  • JVA $18.69
  • IMNN N/A
  • Revenue Growth
  • JVA 17.27
  • IMNN N/A
  • 52 Week Low
  • JVA $0.81
  • IMNN $0.48
  • 52 Week High
  • JVA $4.66
  • IMNN $3.65
  • Technical
  • Relative Strength Index (RSI)
  • JVA 47.99
  • IMNN 47.27
  • Support Level
  • JVA $3.92
  • IMNN $0.80
  • Resistance Level
  • JVA $4.66
  • IMNN $0.88
  • Average True Range (ATR)
  • JVA 0.40
  • IMNN 0.05
  • MACD
  • JVA -0.07
  • IMNN 0.00
  • Stochastic Oscillator
  • JVA 22.22
  • IMNN 25.00

About IMNN Imunon Inc.

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.

Share on Social Networks: